NIH entered into a 10-year agreement to transfer funds from the budget of the National Institute of Allergy and Infectious Diseases (NIAID) to US Department of Defense research. The funds will be used for personnel and projects supporting the development of medical countermeasures against pandemic influenza, chemical, biological, radiological and nuclear (CBRN) threats, and emerging infectious diseases. Congress allocated $6.6 billion for NIAID in 2026; however, the amount to be transferred was not specified. According to a report by Nature, the Department of Defense requested up to one-third of the budget but was asked to settle for approximately 10%. Although the 2026 Department of Defense budget is approximately $1 trillion, it is under pressure because of the open-ended nature of the conflict with Iran.
The agreement was announced at a time when NIH was unable to provide enough grants to use the money appropriated by Congress. Senator Patty Murray (D-Wash.) argued that this was a way to transfer money to the Pentagon without congressional approval. Some believe that biodefense research will be shifted from NIH to the Pentagon. Yet NIH and NIAID leaders had recommended in a commentary published this year that research on biological defense and pandemic preparedness be abandoned. The consequences of the agreement will remain unclear until spending data are disclosed.
Why it matters
This arrangement is intensifying the debate over the authority governing how the funding designated by Congress for NIAID will be used between health research and defense priorities. In particular, NIH’s inability to provide enough grants to use the allocated budget raises the question of whether the transfer is filling an institutional gap or redirecting biodefense research to the Pentagon over the long term. The ten-year framework is turning the question of which institution’s priorities will shape personnel and projects into an issue that researchers and public health circles will closely monitor. However, without knowing the size of the transfer and the expenditure items, it is not possible to assess how much of NIAID’s $6.6 billion 2026 budget will be affected or to what extent its use will remain aligned with the purposes set by Congress.